The antioxidant action of EOCZ was likely the main mechanism of action in the reversal of this lesion, so more tests should be performed for its confirmation.

Aim We aimed to evaluate whether the streptozotocin‐induced diabetic model can generate lung functional, histological and biochemical impairments and whether moderate exercise can prevent these changes. Methods Wistar rats were assigned to control (CTRL), exercise (EXE), diabetic (D) and diabetic with exercise (D+EXE) groups. We used the n5‐STZ model of diabetes mellitus triggered by a single injection of streptozotocin (STZ, 120 mg/kg b.w., i.p.) in newborn rats on their 5th day of life. EXE and D+EXE rats were trained by running on a motorized treadmill, 5 days a week for 9 weeks. Blood glucose, body weight, food intake, exercise capacity, lung mechanics, morphology, and antioxidant enzymatic activity were analysed. Results On the 14th week of life, diabetic rats exhibited a significant impairment in post‐prandial glycaemia, glucose tolerance, body weight, food intake, lung function (tissue viscance, elastance, Newtonian resistance and hysteresis), morphological parameters, redox balance and exercise capacity. Physical training completely prevented the diabetes‐induced alterations, except for those on fasting blood glucose, which nevertheless remained stable. Conclusions Mild diabetes in n5‐STZ‐treated rats jeopardized pulmonary mechanics, morphology and redox balance, which confirms the occurrence of diabetes‐induced pneumopathy. Moreover, moderate exercise completely prevented all diabetes‐induced respiratory alterations.

No abstract

We aimed at evaluating the anti-asthmatic effect of cis-[Ru(bpy)2(2-MIM)(NO)](PF6)3 (FOR811A), a nitrosyl-ruthenium compound, in a murine model of allergic asthma. The anti-asthmatic effects were analyzed by measuring the mechanical lung and morphometrical parameters in female Swiss mice allocated in the following groups: untreated control (Ctl+Sal) and control treated with FOR811A (Ctl+FOR), along asthmatic groups untreated (Ast+Sal) and treated with FOR811A (Ast+FOR). The drug-protein interaction was evaluated by in-silico assay using molecular docking. The results showed that the use of FOR811A in experimental asthma (Ast+FOR) decreased the pressure-volume curve, hysteresis, tissue elastance, tissue resistance, and airway resistance, similar to the control groups (Ctl+Sal; Ctl+FOR). However, it differed from the untreated asthmatic group (Ast+Sal, p<0.05), indicating that FOR811A corrected the lung parenchyma and relaxed the smooth muscles of the bronchi. Similar to control groups (Ctl+Sal; Ctl+FOR), FOR811A increased the inspiratory capacity and static compliance in asthmatic animals (Ast+Sal, p<0.05), showing that this metallodrug improved the capacity of inspiration during asthma. The morphometric parameters showed that FOR811A decreased the alveolar collapse and kept the bronchoconstriction during asthma. Beyond that, the molecular docking using FOR811A showed a strong interaction in the distal portion of the heme group of the soluble guanylate cyclase, particularly with cysteine residue (Cys141). In summary, FOR811A relaxed bronchial smooth muscles and improved respiratory mechanics during asthma, providing a protective effect and promising use for the development of an anti-asthmatic drug.

Most of the energy consumed worldwide comes from non-renewable sources, such as oil derivatives, making it necessary to search for renewable, clean energy sources, with emphasis on biomass from agricultural and industrial waste. Coconut shell pellets (CSPs) and cashew nut shell pellets (CNSPs) were manufactured and subsequently subjected to chemical, thermal and exhaust gas analyses of their combustion. Mean temperature results in the combustion area were 366.44 ± 84.79°C (CSPs) and 295.00 ± 89.47°C (CNSPs). The exhaust gas combustion values were 19.43 ± 0.57% (CSPs) and 18.75 ± 0.77% (CNSPs) of O2, 2348 ± 1241 ppm (CSPs) and 2901 ± 499 ppm (CNSPs) of CO, 14.92 ± 5.06 ppm (CSPs) and 39.83 ± 10.91 ppm (CNSPs) of NOx, and 441.25 ± 130.41 ppm (CSPs) and 2841.50 ± 765.26 ppm (CNSPs) of CH4. In conclusion, the combustion process of CSPs proved to be less polluting and more energy efficient when compared with CNSPs. The analyses of the exhaust gases from the combustion of these biomasses can serve as a basis for the creation of safety parameters and public policies to regulate the use of biomass for energy purposes.

No abstract

No abstract

No abstract